Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I

被引:5
作者
Yousefi, Maria [1 ]
Sudarsan, Arun Kumar Annan [1 ,2 ]
Gaba, Amit [1 ]
Chelico, Linda [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
[2] Ctr Commercializat Regenerat Med CCRM, 661 Univ Ave 1002, Toronto, ON M5G 1M1, Canada
来源
VIRUSES-BASEL | 2023年 / 15卷 / 02期
基金
加拿大健康研究院;
关键词
restriction factor; HIV-1; APOBEC3; HEPATITIS-B-VIRUS; CBF-BETA; RESTRICTION; RNA; POLYMORPHISMS; HYPERMUTATION; DIMERIZATION; DEAMINATION; INHIBITION; EVOLUTION;
D O I
10.3390/v15020463
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteasome. APOBEC3F and APOBEC3G can hetero-oligomerize, which increases their restriction capacity and resistance to Vif. Here we determined if APOBEC3C, APOBEC3F, or APOBEC3G could hetero-oligomerize with APOBEC3H haplotype I. APOBEC3H haplotype I has a short half-life in cells due to ubiquitination and degradation by host proteins, but is also resistant to Vif. We hypothesized that hetero-oligomerization with APOBEC3H haplotype I may result in less Vif-mediated degradation of the interacting APOBEC3 and stabilize APOBEC3H haplotype I, resulting in more efficient HIV-1 restriction. Although we found that all three APOBEC3s could interact with APOBEC3H haplotype I, only APOBEC3F affected APOBEC3H haplotype I by surprisingly accelerating its proteasomal degradation. However, this increased APOBEC3F levels in cells and virions in the absence or presence of Vif and enabled APOBEC3F-mediated restriction of HIV-1 in the presence of Vif. Altogether, the data suggest that APOBEC3 enzymes can co-regulate each other at the protein level and that they cooperate to ensure HIV-1 inactivation rather than evolution.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] APOBEC3 Hypermutations in HIV-1 Infected Cases in Turkey
    Sayan, Murat
    Simsek, Funda
    Ceran, Nurgul
    Dokuzocuz, Basak
    Eraksoy, Haluk
    MIKROBIYOLOJI BULTENI, 2013, 47 (03): : 482 - 492
  • [22] Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest
    Salamango, Daniel J.
    Harris, Reuben S.
    FRONTIERS IN MICROBIOLOGY, 2021, 11
  • [23] Structural Insights into HIV-1 Vif-APOBEC3F Interaction
    Nakashima, Masaaki
    Ode, Hirotaka
    Kawamura, Takashi
    Kitamura, Shingo
    Naganawa, Yuriko
    Awazu, Hiroaki
    Tsuzuki, Shinya
    Matsuoka, Kazuhiro
    Nemoto, Michiko
    Hachiya, Atsuko
    Sugiura, Wataru
    Yokomaku, Yoshiyuki
    Watanabe, Nobuhisa
    Iwatani, Yasumasa
    JOURNAL OF VIROLOGY, 2016, 90 (02) : 1034 - 1047
  • [24] Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway
    Kamba, Keisuke
    Wan, Li
    Unzai, Satoru
    Morishita, Ryo
    Takaori-Kondo, Akifumi
    Nagata, Takashi
    Katahira, Masato
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 294 - 306
  • [25] Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies
    Mohammadzadeh, Nazanin
    Follack, Tyson B.
    Love, Robin P.
    Stewart, Kris
    Sanche, Stephen
    Chelico, Linda
    VIROLOGY, 2019, 527 : 21 - 31
  • [26] APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese
    Sakurai, Daisuke
    Iwatani, Yasumasa
    Ohtani, Hitoshi
    Naruse, Taeko K.
    Terunuma, Hiroshi
    Sugiura, Wataru
    Kimura, Akinori
    IMMUNOGENETICS, 2015, 67 (04) : 253 - 257
  • [27] The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches
    Richards, Christopher
    Albin, John S.
    Demir, Ozlem
    Shaban, Nadine M.
    Luengas, Elizabeth M.
    Land, Allison M.
    Anderson, Brett D.
    Holten, John R.
    Anderson, John S.
    Harki, Daniel A.
    Amaro, Rommie E.
    Harris, Reuben S.
    CELL REPORTS, 2015, 13 (09): : 1781 - 1788
  • [28] Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H
    Ito, Fumiaki
    Alvarez-Cabrera, Ana L.
    Kim, Kyumin
    Zhou, Z. Hong
    Chen, Xiaojiang S.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [29] A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
    Wiegand, HL
    Doehle, BP
    Bogerd, HP
    Cullen, BR
    EMBO JOURNAL, 2004, 23 (12) : 2451 - 2458
  • [30] Identification of HIV-1 Vif Regions Required for CBF-β Interaction and APOBEC3 Suppression
    Wang, Hong
    Liu, Bin
    Liu, Xin
    Li, Zhaolong
    Yu, Xiao-Fang
    Zhang, Wenyan
    PLOS ONE, 2014, 9 (05):